Current and historical daily PE Ratio for Active Biotech AB (
) from 2013 to Jun 13 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Active Biotech AB stock (ATVBY) PE ratio as of Jun 13 2024 is 0.
More Details
Active Biotech AB (ATVBY) PE Ratio (TTM) Chart
Active Biotech AB (ATVBY) PE Ratio (TTM) Historical Data
View and export this data going back to 2013. Start your Free Trial
Total 0
- 1
| Active Biotech AB PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
Active Biotech AB (ATVBY) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Active Biotech AB
ISIN : US00508J1051
Share Class Description:
ATVBY: ADRCompare
Compare
Traded in other countries / regions
ACTI.SwedenBTPC.Germany0GQU.UK IPO Date
2013-04-11Description
Active Biotech AB focuses on the research and development of pharmaceuticals products within medical areas including neurodegenerative diseases, autoimmune/inflammatory disease and various forms of cancer. Its project portfolio contains both small molecules that are orally active immunomodulatory agents and antibody based immunotherapy.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers